A Pilot Study of Virtual Reality and Antigravity Treadmill for Gait Improvement in Parkinson
NCT ID: NCT04117737
Last Updated: 2020-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2019-09-30
2019-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Virtual Reality-based Interactive Treadmill Gait Training System for Parkinson's Disease
NCT03686462
Immersive Virtual Reality to Improve Gait in Parkinson's Disease
NCT03727529
Effects of iVR Treadmill on Gait in PD
NCT04019158
Effects of a Treadmill Gait Training Protocol in a Gamified Virtual Reality Environment With tDCS in Parkinson's Disease
NCT05243394
Virtual Reality on Balance of Parkinson's Disease
NCT07274514
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Single-arm
Virtual reality combined with anti-gravity treadmill
The system is composed of three major parts: the treadmill, the antigravity system and the virtual reality system.
The treadmill is the base of the device. It is a rounded and concave structure that permits to walk in all direction. For simulate anti-gravity, a harness and pulley system allow to regulate the weight. Finally, the virtual reality system enables participants to simulate an experience of daily life.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Virtual reality combined with anti-gravity treadmill
The system is composed of three major parts: the treadmill, the antigravity system and the virtual reality system.
The treadmill is the base of the device. It is a rounded and concave structure that permits to walk in all direction. For simulate anti-gravity, a harness and pulley system allow to regulate the weight. Finally, the virtual reality system enables participants to simulate an experience of daily life.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having an alteration of the gait caused by the neurological disorder.
* Being able to have an independent and voluntary walk of 10 meters as minimum.
* Height more than 150 cm.
Exclusion Criteria
* Medical contraindications for walking.
* Being amputee.
* Alcohol or drugs abuse.
* Other diseases that impedes the intervention.
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad San Jorge
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pablo Herrero, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidad San Jorge
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Asociación de Parkinson de Aragón
Zaragoza, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI18/386
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.